Role of mineralocorticoid receptors in arterial stiffness in human aging

Experimental Gerontology

Volumn 48, Issue 8, 2013, Pages 701-704

  Hwang, Moon Hyon ^a   Yoo, Jeung Ki ^a   Luttrell, Meredith ^b   Kim, Han Kyul ^a   Meade, Thomas H ^b   English, Mark ^c   Nichols, Wilmer W ^d   Christou, Demetra D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Arterial stiffness; Augmentation index; Compliance; Oxidative stress; Pulse wave velocity

Indexed keywords

EPLERENONE; MINERALOCORTICOID RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO;

ADULT; AGED; AGING; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE WAVE;

AGING; ARTERIAL STIFFNESS; AUGMENTATION INDEX; COMPLIANCE; OXIDATIVE STRESS; PULSE WAVE VELOCITY;

AGED; AGING; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; OXIDATIVE STRESS; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; VASCULAR STIFFNESS;

EID: 84879250571     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.05.058     Document Type: Article

References (27)

1. Adler A., Messina E., Sherman B., Wang Z., Huang H., Linke A., Hintze T.H. NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1015-H1022.
2. Armentano R., Megnien J.L., Simon A., Bellenfant F., Barra J., Levenson J. Effects of hypertension on viscoelasticity of carotid and femoral arteries in humans. Hypertension 1995, 26:48-54.
3. Christou D.D., Gentile C.L., DeSouza C.A., Seals D.R., Gates P.E. Fatness is a better predictor of cardiovascular disease risk factor profile than aerobic fitness in healthy men. Circulation 2005, 111:1904-1914.
4. de Gasparo M., Joss U., Ramjoue H.P., Whitebread S.E., Haenni H., Schenkel L., Kraehenbuehl C., Biollaz M., Grob J., Schmidlin J., et al. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J. Pharmacol. Exp. Ther. 1987, 240:650-656.
5. Gates P.E., Tanaka H., Hiatt W.R., Seals D.R. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension 2004, 44:35-41.
6. Hirai T., Sasayama S., Kawasaki T., Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989, 80:78-86.
7. Jeunemaitre X., Charru A., Chatellier G., Degoulet P., Julien J., Plouin P.F., Corvol P., Menard J. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension. Am. J. Cardiol. 1988, 62:1072-1077.
8. Keidar S., Kaplan M., Pavlotzky E., Coleman R., Hayek T., Hamoud S., Aviram M. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 2004, 109:2213-2220.
9. Kinlay S., Creager M.A., Fukumoto M., Hikita H., Fang J.C., Selwyn A.P., Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001, 38:1049-1053.
10. Mackenzie I.S., McEniery C.M., Dhakam Z., Brown M.J., Cockcroft J.R., Wilkinson I.B. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009, 54:409-413.
11. McCurley A., Jaffe I.Z. Mineralocorticoid receptors in vascular function and disease. Mol. Cell. Endocrinol. 2012, 350:256-265.
12. McCurley A., Pires P.W., Bender S.B., Aronovitz M., Zhao M.J., Metzger D., Chambon P., Hill M.A., Dorrance A.M., Mendelsohn M.E., Jaffe I.Z. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med. 2012, 18:1429-1433.
13. Meaume S., Benetos A., Henry O.F., Rudnichi A., Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70years of age. Arterioscler. Thromb. Vasc. Biol. 2001, 21:2046-2050.
14. Mitchell G.F. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J. Appl. Physiol. 2008, 105:1652-1660.
15. Moreau K.L., Gavin K.M., Plum A.E., Seals D.R. Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women. Hypertension 2005, 45:1107-1112.
16. Mullan B.A., Young I.S., Fee H., McCance D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002, 40:804-809.
17. Nashar K., Nguyen J.P., Jesri A., Morrow J.D., Egan B.M. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am. J. Hypertens. 2004, 17:477-482.
18. Nguyen Dinh Cat A., Griol-Charhbili V., Loufrani L., Labat C., Benjamin L., Farman N., Lacolley P., Henrion D., Jaisser F. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J. 2010, 24:2454-2463.
19. O'Rourke M.F., Staessen J.A., Vlachopoulos C., Duprez D., Plante G.E. Clinical applications of arterial stiffness; definitions and reference values. Am. J. Hypertens. 2002, 15:426-444.
20. Rajagopalan S., Duquaine D., King S., Pitt B., Patel P. Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 2002, 105:2212-2216.
21. Reneman R.S., Meinders J.M., Hoeks A.P. Non-invasive ultrasound in arterial wall dynamics in humans: what have we learned and what remains to be solved. Eur. Heart J. 2005, 26:960-966.
22. Rossignol P., Menard J., Fay R., Gustafsson F., Pitt B., Zannad F. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J. Am. Coll. Cardiol. 2011, 58:1958-1966.
23. Sartorio C.L., Fraccarollo D., Galuppo P., Leutke M., Ertl G., Stefanon I., Bauersachs J. Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension 2007, 50:919-925.
24. Sindler A.L., Fleenor B.S., Calvert J.W., Marshall K.D., Zigler M.L., Lefer D.J., Seals D.R. Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell 2011, 10:429-437.
25. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., Venkitachalam L., Kupelian V., Simonsick E.M., Havlik R., Lakatta E.G., Spurgeon H., Kritchevsky S., Pahor M., Bauer D., Newman A. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005, 111:3384-3390.
26. Tanaka H., Dinenno F.A., Monahan K.D., Clevenger C.M., DeSouza C.A., Seals D.R. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000, 102:1270-1275.
27. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 55:1318-1327.